According to a recent study, a monoclonal antibody against ADAM17, D8P1C1, effectively inhibited the proliferation of breast, ovarian, glioma, colon, and lung adenocarcinoma cells [36]. The gene discussed is ADAM17; the disease is central nervous system cancer.